
AstraZeneca Pharma India Limited
NSE:ASTRAZEN.NS
7884.5 (INR) • At close May 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||
Current Assets: | ||||||||||||||||||||
Cash & Cash Equivalents
| 5,055.7 | 5,003.4 | 4,484.2 | 3,523.4 | 835 | 1,732.4 | 1,139.8 | 1,145.5 | 762 | 14.386 | 46.77 | 4.621 | 15.486 | 853.902 | 682.354 | 1,438.039 | 1,110.355 | 1,080.005 | 671.461 | 43.534 |
Short Term Investments
| 0 | 107.145 | 0 | 56.56 | 1,690 | 55.6 | 116.8 | 6.1 | 0.095 | 225 | 830 | 165.019 | 500.069 | 0 | 0 | 0 | 0 | 152.119 | 165.161 | 668.677 |
Cash and Short Term Investments
| 5,055.7 | 5,110.545 | 4,484.2 | 3,523.4 | 2,525 | 1,732.4 | 1,256.6 | 1,151.6 | 768.1 | 239.386 | 876.77 | 169.64 | 515.555 | 853.902 | 682.354 | 1,438.039 | 1,110.355 | 1,080.005 | 836.622 | 712.211 |
Net Receivables
| 1,693 | 1,183.1 | 858.9 | 851.9 | 832.1 | 861.9 | 586.8 | 430 | 784.218 | 0 | 0 | 0 | 682.195 | 0 | 916.786 | 0 | 632.181 | 588.276 | 447.124 | 311.092 |
Inventory
| 2,278.8 | 1,902.1 | 1,402.2 | 1,598 | 1,651.5 | 1,181 | 1,131.5 | 577.1 | 767.296 | 861.307 | 957.576 | 853.691 | 750.969 | 572.026 | 352.001 | 340.064 | 237.879 | 348.695 | 251.22 | 264.863 |
Other Current Assets
| 286.8 | 260.2 | 311.4 | 214.3 | 414.6 | 336.3 | 274.8 | 356.8 | 369.322 | 9.67 | 15.908 | 14.725 | 26.887 | 769.574 | 54.632 | 781.185 | 122.898 | 38.893 | 50.639 | 47.155 |
Total Current Assets
| 9,327.1 | 8,354.7 | 7,056.7 | 6,187.6 | 5,423.2 | 4,047.2 | 3,209.2 | 2,515.5 | 2,682.841 | 2,632.605 | 2,746.243 | 1,648.106 | 1,975.607 | 2,195.501 | 2,005.773 | 2,559.288 | 2,109.943 | 2,055.869 | 1,429.979 | 1,335.321 |
Non-Current Assets: | ||||||||||||||||||||
Property, Plant & Equipment, Net
| 648.4 | 701.9 | 766.9 | 849.8 | 960.1 | 835.7 | 800 | 916.488 | 1,038.292 | 1,131.941 | 1,035.309 | 982.415 | 901.824 | 513.877 | 273.368 | 274.435 | 302.27 | 302.699 | 312.155 | 293.066 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.151 | 0 | 0 | 0 | 0 |
Intangible Assets
| 21.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.068 | 30.068 | 30.068 | 30.068 | 0 | 0 |
Goodwill and Intangible Assets
| 21.1 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | 500.012 | 0 | 30.068 | 12.917 | 30.068 | 30.068 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | -27 | 0 | 0 | 0.005 | -224.995 | -829.995 | -164.962 | -500.012 | 0 | 0 | 17.151 | 0 | -152.053 | -165.039 | 0.572 |
Tax Assets
| 212.5 | 206.7 | 163 | 145.3 | 146.4 | 233.6 | 325.5 | 402.2 | 0 | 0 | 0 | 0 | 177.623 | 75.419 | 29.4 | 23.712 | 17.263 | 9.812 | 12.241 | 45.402 |
Other Non-Current Assets
| 571.2 | 585.4 | 579 | 564.4 | 533.9 | 528.5 | 270.7 | 320.712 | 790.603 | 576.377 | 1,224.2 | 595.458 | 865.801 | 302.022 | 0.057 | 17.208 | 0.066 | 304.239 | 165.161 | 0 |
Total Non-Current Assets
| 1,453.2 | 1,494 | 1,508.9 | 1,559.5 | 1,640.4 | 1,570.8 | 1,396.2 | 1,639.4 | 1,828.9 | 1,483.323 | 1,429.514 | 1,412.91 | 1,445.235 | 891.318 | 332.893 | 328.272 | 349.668 | 342.645 | 324.519 | 339.041 |
Total Assets
| 10,780.3 | 9,848.7 | 8,565.6 | 7,747.1 | 7,063.6 | 5,618 | 4,605.4 | 4,154.9 | 4,487.3 | 4,115.928 | 4,155.875 | 3,061.017 | 3,420.842 | 3,086.82 | 2,338.666 | 2,887.56 | 2,459.611 | 2,398.514 | 1,754.498 | 1,674.362 |
Liabilities & Equity: | ||||||||||||||||||||
Current Liabilities: | ||||||||||||||||||||
Account Payables
| 1,965.1 | 2,278.8 | 1,904.4 | 1,783.7 | 2,097.2 | 1,682 | 1,007 | 876.6 | 946.284 | 1,112.716 | 1,098.71 | 906.722 | 177.654 | 143.758 | 402.773 | 367.077 | 41.225 | 332.842 | 2.051 | 29.062 |
Short Term Debt
| 18.1 | 35.2 | 36.1 | 35.1 | 25.4 | 0 | 0 | 0 | 0 | 6.061 | 2.752 | 2.913 | 2.913 | 0 | 9.86 | 9.86 | 9.86 | 9.86 | 9.86 | 0 |
Tax Payables
| 66.61 | 24.229 | 49.4 | 56.3 | 21 | 18.3 | 53.6 | 53.9 | 78.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 496.1 | 401.7 | 306.9 | 128.3 | 0 | 0 | 0 | 96.8 | 0 | 0 | 0 | 0 | 0 | 0 | 431.498 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 1,025.29 | 1,099.371 | 1,029.7 | 1,031.6 | 1,128.8 | 889.5 | 1,008.9 | 876.1 | 1,459.464 | 1,479.409 | 1,333.569 | 1,148.959 | 1,341.98 | 1,109.931 | 49.353 | 724.126 | 817.993 | 638.571 | 470.633 | 649.084 |
Total Current Liabilities
| 3,571.2 | 3,839.3 | 3,326.5 | 3,035 | 3,272.4 | 2,589.8 | 2,069.5 | 1,903.4 | 2,484.398 | 2,598.185 | 2,435.031 | 2,058.594 | 1,522.546 | 1,253.689 | 893.484 | 1,101.063 | 869.078 | 981.273 | 482.544 | 678.146 |
Non-Current Liabilities: | ||||||||||||||||||||
Long Term Debt
| 27.8 | 36.9 | 50.2 | 86.3 | 93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 625 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.818 |
Other Non-Current Liabilities
| 62.1 | 85.6 | 75 | 64.1 | 53.8 | 20.2 | 66.6 | 22.8 | 21.6 | 10.189 | 4.894 | 4.894 | 5.444 | 36.235 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 89.9 | 122.5 | 125.2 | 150.4 | 146.8 | 20.2 | 66.6 | 22.8 | 21.6 | 10.189 | 4.894 | 4.894 | 5.444 | 36.235 | 0 | 625 | 0 | 0 | 0 | 40.818 |
Total Liabilities
| 3,661.1 | 3,961.969 | 3,451.7 | 3,185.4 | 3,419.2 | 2,610 | 2,136.1 | 1,972.882 | 2,497.068 | 2,608.375 | 2,439.924 | 2,063.487 | 1,527.99 | 1,289.924 | 893.484 | 1,726.063 | 869.078 | 981.273 | 482.544 | 718.964 |
Equity: | ||||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
Retained Earnings
| 5,781.5 | 4,556.4 | 3,789.6 | 3,241 | 2,323.7 | 1,682.2 | 1,143.7 | 907.4 | 255.325 | 202.735 | 411.132 | 947.529 | 1,311.544 | 1,746.896 | 1,395.182 | 1,111.497 | 1,543.096 | 1,367.241 | 1,221.954 | 0 |
Accumulated Other Comprehensive Income/Loss
| 564.2 | 557 | 550.8 | 547.2 | 1,270.7 | 1,275.8 | 1,275.6 | 1,271.3 | 723.51 | 1,254.818 | 1,254.818 | 0 | 0 | 511.543 | 0 | 0 | 0 | 0 | 0 | 905.398 |
Other Total Stockholders Equity
| 723.5 | 723.5 | 723.5 | 723.5 | 0 | 0 | 0 | 0 | 531.308 | 0 | 0 | 0 | 531.308 | -511.543 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 7,119.2 | 5,886.9 | 5,113.9 | 4,561.7 | 3,644.4 | 3,008 | 2,469.3 | 2,228.7 | 1,560.143 | 1,507.553 | 1,715.95 | 997.529 | 1,892.852 | 1,796.896 | 1,445.182 | 1,161.497 | 1,593.096 | 1,417.241 | 1,271.954 | 955.398 |
Total Equity
| 7,119.2 | 5,886.9 | 5,113.9 | 4,561.7 | 3,644.4 | 3,008 | 2,469.3 | 2,228.7 | 1,560.143 | 1,507.553 | 1,715.95 | 997.529 | 1,892.852 | 1,796.896 | 1,445.182 | 1,161.497 | 1,593.096 | 1,417.241 | 1,271.954 | 955.398 |
Total Liabilities & Shareholders Equity
| 10,780.3 | 9,848.852 | 8,565.6 | 7,747.1 | 7,063.6 | 5,618 | 4,605.4 | 4,154.9 | 4,057.211 | 4,115.928 | 4,155.875 | 3,061.017 | 3,420.842 | 3,086.82 | 2,338.666 | 2,887.56 | 2,462.173 | 2,398.514 | 1,754.498 | 1,674.362 |